U.S. Markets open in 6 hrs 3 mins

Chemomab Therapeutics Ltd. (CMMB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
12.17-0.18 (-1.46%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close12.35
Open12.35
Bid12.12 x 900
Ask12.80 x 900
Day's Range12.08 - 12.41
52 Week Range11.30 - 168.80
Volume38,535
Avg. Volume169,960
Market Cap133.905M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateMay 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est43.50
  • PR Newswire

    Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer

    Chemomab Therapeutics Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for inflammatory and fibrotic diseases with high unmet need, today announced it has appointed Dale R. Pfost, PhD, as Chief Executive Officer (CEO). Dr. Adi Mor, Company co-founder and current CEO, will continue in her role as Chief Scientific Officer (CSO) and remain as a member of the Board of Directors. The addition of Dr. Pfost, who brings more than 3

  • PR Newswire

    Chemomab to Participate in Upcoming September Investor Conferences

    Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, today announced that the Company will participate in the following upcoming investor conferences in September:

  • PR Newswire

    Chemomab Therapeutics Announces Second Quarter 2021 Financial Results and Provides a Business Update

    Chemomab Therapeutics Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, today announced financial and operating results for the second quarter ended June 30, 2021 and provided a business update.